Literature DB >> 7529365

Viral dynamics in human immunodeficiency virus type 1 infection.

X Wei1, S K Ghosh, M E Taylor, V A Johnson, E A Emini, P Deutsch, J D Lifson, S Bonhoeffer, M A Nowak, B H Hahn.   

Abstract

The dynamics of HIV-1 replication in vivo are largely unknown yet they are critical to our understanding of disease pathogenesis. Experimental drugs that are potent inhibitors of viral replication can be used to show that the composite lifespan of plasma virus and virus-producing cells is remarkably short (half-life approximately 2 days). Almost complete replacement of wild-type virus in plasma by drug-resistant variants occurs after fourteen days, indicating that HIV-1 viraemia is sustained primarily by a dynamic process involving continuous rounds of de novo virus infection and replication and rapid cell turnover.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7529365     DOI: 10.1038/373117a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  911 in total

1.  Decreased processivity of human immunodeficiency virus type 1 reverse transcriptase (RT) containing didanosine-selected mutation Leu74Val: a comparative analysis of RT variants Leu74Val and lamivudine-selected Met184Val.

Authors:  P L Sharma; C S Crumpacker
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Linkage disequilibrium test implies a large effective population number for HIV in vivo.

Authors:  I M Rouzine; J M Coffin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

3.  A simple relationship between viral load and survival time in HIV-1 infection.

Authors:  R A Arnaout; A L Lloyd; T R O'Brien; J J Goedert; J M Leonard; M A Nowak
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

4.  Benchmarks for antiretroviral therapy.

Authors:  O J Cohen; A S Fauci
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

5.  A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children.

Authors:  D Persaud; T Pierson; C Ruff; D Finzi; K R Chadwick; J B Margolick; A Ruff; N Hutton; S Ray; R F Siliciano
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

Review 6.  Monitoring patients with HIV disease.

Authors:  M Helbert; J Breuer
Journal:  J Clin Pathol       Date:  2000-04       Impact factor: 3.411

Review 7.  Quantitative molecular analysis of virus expression and replication.

Authors:  M Clementi
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

8.  Functional reconstitution of thymopoiesis after human immunodeficiency virus infection.

Authors:  S G Kitchen; S Killian; J V Giorgi; J A Zack
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

9.  Antigen-driven CD4+ T cell and HIV-1 dynamics: residual viral replication under highly active antiretroviral therapy.

Authors:  N M Ferguson; F deWolf; A C Ghani; C Fraser; C A Donnelly; P Reiss; J M Lange; S A Danner; G P Garnett; J Goudsmit; R M Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

10.  Mechanisms for HIV-1 Entry: Current Strategies to Interfere with This Step.

Authors:  Georgia D. Tomaras; Michael L. Greenberg
Journal:  Curr Infect Dis Rep       Date:  2001-02       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.